It’s the most wonderful time of the year! Some people have Christmas in July. Or the Fourth of July. I have nine days of fandom…
Hope is my Superpower - a Column by Gina Diamante
For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…
Note: This column describes the author’s own thoughts about GLP-1 agonist medications. Not everyone will have the same response to treatment. Consult your doctor before…
Before I got multiple myeloma, I didn’t think much about health insurance. I didn’t even have health insurance 40 years ago! I was young…
About 20 years ago, I worked seven days a week at two different jobs. My weekday job was an hour north of my home, while…
I don’t think it’s any secret that I have a thing for heroes, super-powered or otherwise. Just look at the artwork for this column!…
Watch for a lot of news about myeloma research in the next few weeks. The American Society of Clinical Oncology (ASCO) is about to…
I used to say if I needed to take a pill every day to survive, I’d be dead in a week. So it felt like…
My very first journalism teacher, way back in high school, taught me the importance of “who, what, when, where, and why” as building blocks of…
Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…
Recent Posts
- Study of gynecological cancer therapy moving fast in summer slowdown
- The caregiver’s invisible ledger tracks what no one else sees
- Study shows protein marker helps predict aggressive myeloma
- New combination therapy cuts risk of death in hard-to-treat myeloma
- Early AML trial finds experimental therapy was generally well tolerated
